Citigroup’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $21.1M | Buy |
66,639
+45,045
| +209% | +$10.6M | 0.01% | 1145 |
|
|
2026
Q1 | $4.31M | Buy |
21,594
+3,302
| +18% | +$653K | ﹤0.01% | 2081 |
|
|
2025
Q4 | $3.46M | Sell |
18,292
-3,095
| -14% | -$595K | ﹤0.01% | 2283 |
|
|
2025
Q3 | $3.79M | Sell |
21,387
-8,287
| -28% | -$1.23M | ﹤0.01% | 2182 |
|
|
2025
Q2 | $3.37M | Sell |
29,674
-16
| -0.1% | -$1.71K | ﹤0.01% | 2229 |
|
|
2025
Q1 | $3.12M | Buy |
29,690
+1,702
| +6% | +$192K | ﹤0.01% | 2324 |
|
|
2024
Q4 | $3M | Buy |
27,988
+2,408
| +9% | +$272K | ﹤0.01% | 2457 |
|
|
2024
Q3 | $2.56M | Buy |
25,580
+11,107
| +77% | +$1.12M | ﹤0.01% | 2448 |
|
|
2024
Q2 | $1.22M | Buy |
14,473
+1,211
| +9% | +$96.4K | ﹤0.01% | 2761 |
|
|
2024
Q1 | $969K | Buy |
13,262
+816
| +7% | +$60.2K | ﹤0.01% | 3049 |
|
|
2023
Q4 | $889K | Buy |
12,446
+3,669
| +42% | +$217K | ﹤0.01% | 2925 |
|
|
2023
Q3 | $526K | Sell |
8,777
-7,295
| -45% | -$480K | ﹤0.01% | 3018 |
|
|
2023
Q2 | $1.16M | Buy |
16,072
+3,676
| +30% | +$276K | ﹤0.01% | 2722 |
|
|
2023
Q1 | $912K | Sell |
12,396
-572
| -4% | -$40.7K | ﹤0.01% | 2633 |
|
|
2022
Q4 | $866K | Sell |
12,968
-54,938
| -81% | -$3.57M | ﹤0.01% | 2746 |
|
|
2022
Q3 | $3.65M | Buy |
67,906
+9,174
| +16% | +$539K | ﹤0.01% | 1731 |
|
|
2022
Q2 | $3.27M | Buy |
58,732
+20,359
| +53% | +$1.16M | ﹤0.01% | 1773 |
|
|
2022
Q1 | $2.69M | Sell |
38,373
-29,171
| -43% | -$2.12M | ﹤0.01% | 2105 |
|
|
2021
Q4 | $6.51M | Buy |
67,544
+10,267
| +18% | +$948K | ﹤0.01% | 1653 |
|
|
2021
Q3 | $4.98M | Buy |
57,277
+893
| +2% | +$69.1K | ﹤0.01% | 1836 |
|
|
2021
Q2 | $4.62M | Buy |
56,384
+10,064
| +22% | +$837K | ﹤0.01% | 1962 |
|
|
2021
Q1 | $4.41M | Buy |
46,320
+37,536
| +427% | +$3.55M | ﹤0.01% | 1871 |
|
|
2020
Q4 | $545K | Buy |
8,784
+5,168
| +143% | +$295K | ﹤0.01% | 4128 |
|
|
2020
Q3 | $215K | Sell |
3,616
-23,548
| -87% | -$1.61M | ﹤0.01% | 4563 |
|
|
2020
Q2 | $1.9M | Sell |
27,164
-13,656
| -33% | -$866K | ﹤0.01% | 2870 |
|
|
2020
Q1 | $1.85M | Buy |
40,820
+15,962
| +64% | +$905K | ﹤0.01% | 2550 |
|
|
2019
Q4 | $1.62M | Sell |
24,858
-832
| -3% | -$55.6K | ﹤0.01% | 3236 |
|
|
2019
Q3 | $1.59M | Buy |
25,690
+2,490
| +11% | +$156K | ﹤0.01% | 3120 |
|
|
2019
Q2 | $1.65M | Sell |
23,200
-9,041
| -28% | -$666K | ﹤0.01% | 3077 |
|
|
2019
Q1 | $2.53M | Sell |
32,241
-66,768
| -67% | -$5.06M | ﹤0.01% | 2434 |
|
|
2018
Q4 | $8.38M | Buy |
99,009
+57,022
| +136% | +$6.08M | 0.01% | 1390 |
|
|
2018
Q3 | $7.19M | Buy |
41,987
+30,473
| +265% | +$4.59M | 0.01% | 1524 |
|
|
2018
Q2 | $1.49M | Sell |
11,514
-31,531
| -73% | -$3.52M | ﹤0.01% | 2962 |
|
|
2018
Q1 | $4.43M | Sell |
43,045
-15,219
| -26% | -$1.51M | ﹤0.01% | 1870 |
|
|
2017
Q4 | $4.98M | Buy |
58,264
+8,311
| +17% | +$720K | ﹤0.01% | 1841 |
|
|
2017
Q3 | $4.24M | Sell |
49,953
-1,784
| -3% | -$141K | ﹤0.01% | 1919 |
|
|
2017
Q2 | $3.92M | Buy |
51,737
+4,035
| +8% | +$282K | ﹤0.01% | 1917 |
|
|
2017
Q1 | $3.15M | Sell |
47,702
-88,090
| -65% | -$5.8M | ﹤0.01% | 2043 |
|
|
2016
Q4 | $8.61M | Buy |
135,792
+111,157
| +451% | +$7.01M | 0.01% | 1311 |
|
|
2016
Q3 | $1.57M | Buy |
24,635
+14,972
| +155% | +$1.1M | ﹤0.01% | 2750 |
|
|
2016
Q2 | $719K | Sell |
9,663
-11,208
| -54% | -$832K | ﹤0.01% | 3273 |
|
|
2016
Q1 | $1.39M | Sell |
20,871
-41,793
| -67% | -$2.54M | ﹤0.01% | 2939 |
|
|
2015
Q4 | $4.24M | Buy |
62,664
+2,712
| +5% | +$167K | ﹤0.01% | 1844 |
|
|
2015
Q3 | $3.2M | Buy |
59,952
+57,839
| +2,737% | +$3.51M | ﹤0.01% | 2051 |
|
|
2015
Q2 | $133K | Sell |
2,113
-710
| -25% | -$38.7K | ﹤0.01% | 4780 |
|
|
2015
Q1 | $136K | Sell |
2,823
-17,683
| -86% | -$678K | ﹤0.01% | 4807 |
|
|
2014
Q4 | $681K | Buy |
20,506
+4,551
| +29% | +$148K | ﹤0.01% | 3554 |
|
|
2014
Q3 | $468K | Buy |
15,955
+14,506
| +1,001% | +$482K | ﹤0.01% | 3586 |
|
|
2014
Q2 | $56K | Sell |
1,449
-460
| -24% | -$18.7K | ﹤0.01% | 5090 |
|
|
2014
Q1 | $80K | Sell |
1,909
-8,889
| -82% | -$371K | ﹤0.01% | 5182 |
|
|
2013
Q4 | $355K | Buy |
10,798
+4,307
| +66% | +$140K | ﹤0.01% | 4128 |
|
|
2013
Q3 | $175K | Buy |
6,491
+6,201
| +2,138% | +$174K | ﹤0.01% | 4268 |
|
|
2013
Q2 | $7K | Buy |
+290
| New | +$5.22K | ﹤0.01% | 6229 |
|
Other funds holding LGND
JT
CAM
Citigroup's LGND Position: Q2 2026 in Review
Citigroup increased its Ligand Pharmaceuticals (LGND) stake by 209% in Q2 2026, buying an estimated $10.6M and bringing the position to 66,639 shares worth $21.1M. The position accounts for 0.01% of the portfolio, ranked #1145.
Citigroup first reported a position in LGND in Q2 2013 and has held it in 53 quarters since. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.
- Citigroup held 66,639 shares of Ligand Pharmaceuticals worth $21.1M as of Q2 2026.
- Citigroup bought 45,045 Ligand Pharmaceuticals shares in Q2 2026, an estimated $10.6M.
- Ligand Pharmaceuticals made up 0.01% of Citigroup's portfolio in Q2 2026, its #1145 holding.
- Citigroup first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.